VTGN VistaGen Therapeutics, Inc.
$0.17▼ -2.30%
Healthcare
Other
After hours
$0.17▲ +1.82%
Oct 28, 7:02 PM ET
Volume 860.5K
Avg Volume (10D) 798.2K
Key Metrics & Fundamentals
Market Cap
$7.54M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.17 - 5.14
% vs 50 MA
-29.34%
% vs 200 MA
-62.29%
RSI-14
28.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.22
Free Cash Flow
-$14.71M
Gross Rev
$1.48M
Gross Profit
$1.48M
EBITDA
-$13.15M
COGS
–
Operating Exp
$14.82M
Operating Income
-$13.35M
EBIT
-$13.35M
Pretax Income
-$13.03M
Net Income
-$13.03M
EPS (Diluted)
-0.30
Price & Volume History
Loading chart…
Recent News
Vistagen Selects GATC Health to Apply Predictive AI Across Lead Clinical-Stage Drug Development Programs
GlobeNewswire · Oct 20, 2026 8:30 AM ET
Vasomotor Symptoms Market Poised for Growth Through 2036, Driven by Rising Adoption of Hormonal and Non-Hormonal Therapies | DelveInsight
PR Newswire · Sep 30, 2026 10:31 AM ET
2 Falling Stocks Call Traders Are Targeting Today
Schaeffer's Investment Research · Sep 25, 2026 10:50 AM ET
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
GlobeNewswire · Sep 24, 2026 12:30 PM ET
Vistagen Presents Fasedienol Subgroup Data in Severe Social Anxiety Disorder
InvestorsHub · Sep 24, 2026 9:58 AM ET
Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder
GlobeNewswire · Sep 24, 2026 7:00 AM ET
Top Premarket Gainers
MT Newswires · Sep 23, 2026 7:07 AM ET
Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
GlobeNewswire · Sep 22, 2026 8:30 AM ET
Vistagen to Present at Psych Congress 2026
GlobeNewswire · Sep 10, 2026 8:30 AM ET
Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
GlobeNewswire · Aug 14, 2026 8:32 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See VTGN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.